|
|||||
|
|
Oral administration of Lactobacillus brevis KB290 to mice alleviates clinical symptoms following influenza virus infection |
|
| Authors: | N. Waki N. Yajima H. Suganuma B.M. Buddle D. Luo A. Heiser T. Zheng |
| Affiliation: | 1. Research and Development Division, Kagome Co., Ltd., , Tochigi, Japan;2. AgResearch Ltd., Hopkirk Research Institute, Grasslands Research Centre, , Palmerston North, New Zealand |
| Abstract: | |
| Keywords: | immunoglobulin A influenza virus interferon‐α Lactobacillus probiotics |